Antoine Francis: Building the Future of Plasma Supply with Quality, Traceability, and Purpose
Antoine Francis shared a post from Global Plasma Supply on LinkedIn:
“At Global Plasma Supply, we don’t just operate—we stand.
On three pillars engraved into every decision we make:
Quality. Traceability. Purpose.
These aren’t taglines. They are non-negotiables.
They are the foundation for how we collect, protect, and transform plasma into life-saving therapies—ethically and globally.
From donor to vial, from first touch to final dose, our systems ensure:
- Nothing is lost.
- No life is compromised.
- Every drop fulfills its calling.
In a world where regulatory shadows still linger and untraceable plasma slips into questionable circuits, we don’t flinch.
We draw the line.
Only trusted, traceable, purpose-bound plasma has a place in the future of healthcare.
And at GPS—we build that future, drop by drop.”
Read the full article here:
Stay informed on the emerging news in Hematology with Hemostasis Today.
-
Feb 28, 2026, 17:03Investing in Education, Prevention, and Lifesaving Research for a Healthier Tomorrow – AHA
-
Feb 28, 2026, 17:00Pamela Gavin: 1 in 10 Americans Live With A Rare Disease – That Is Not Rare, That Is Public Health
-
Feb 28, 2026, 16:59Thomas Rocco Jr: Exploring Agentic AI in Cardiovascular Medicine
-
Feb 28, 2026, 16:50Rob Maloney: Normalcy Is Not A Small Thing In Rare Disease
-
Feb 28, 2026, 16:49Céline Chapelle: Evaluating 6-Month Risks of Recurrent VTE and Major Bleeding With Tinzaparin
-
Feb 28, 2026, 16:46Nicolas Hulscher: Nattokinase Dissolves 84% of Amyloid Microclots In Vitro
-
Feb 28, 2026, 16:46Alfonso Tafur: Preventing Post-Hospitalization Blood Clots Using Precision Tools and Systems
-
Feb 28, 2026, 16:39Anel Karisik: Do Antidepressants Influence Swallowing Recovery After Acute Ischemic Stroke?
-
Feb 28, 2026, 16:38Akinchan Bhardwaj: Targeting SBK2 for Selective Inflammasome Resolution in Atherosclerosis